Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|October 11, 2011
Synthesis of purine modified 2'-C-methyl nucleosides as potential anti-HCV agentsHong-wang Zhang, Longhu Zhou, Steven J Coats, et al.Bioorganic & Medicinal Chemistry Letters|April 18, 2012
Synthesis and biological evaluation of new potent and selective HCV NS5A inhibitorsJunxing Shi, Longhu Zhou, Franck Amblard, et al.Bioorganic & Medicinal Chemistry Letters|October 22, 2011
Synthesis and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methyl-7-deazapurine nucleosides, their phosphoramidate prodrugs and 5'-triphosphatesJunxing Shi, Longhu Zhou, Hongwang Zhang, et al.Bioorganic & Medicinal Chemistry Letters|March 8, 2013
Synthesis and evaluation of non-dimeric HCV NS5A inhibitorsFranck Amblard, Hongwang Zhang, Longhu Zhou, et al.Journal of Medicinal Chemistry|November 4, 2014
Asymmetric binding to NS5A by daclatasvir (BMS-790052) and analogs suggests two novel modes of HCV inhibitionJames H Nettles, Richard A Stanton, Joshua Broyde, et al.Antimicrobial Agents and Chemotherapy|June 1, 2017
Nucleotide Substrate Specificity of Anti-Hepatitis C Virus Nucleoside Analogs for Human Mitochondrial RNA PolymeraseMaryam Ehteshami, Longhu Zhou, Sheida Amiralaei, et al.Journal of Medicinal Chemistry|April 8, 2015
β-D-2'-C-Methyl-2,6-diaminopurine Ribonucleoside Phosphoramidates are Potent and Selective Inhibitors of Hepatitis C Virus (HCV) and Are Bioconverted Intracellularly to Bioactive 2,6-Diaminopurine and Guanosine 5'-Triphosphate FormsLonghu Zhou, Hong-wang Zhang, Sijia Tao, et al.RSC Medicinal Chemistry|January 5, 2026
Prodrug strategies in developing antiviral nucleoside analogsR Rama Suresh, Tuniyazi Abuduani, Mahesh Kasthuri, et al.Antimicrobial Agents and Chemotherapy|May 8, 2019
Nucleoside Analogs with Selective Antiviral Activity against Dengue Fever and Japanese Encephalitis VirusesKeivan Zandi, Leda Bassit, Franck Amblard, et al.Science Advances|October 3, 2025
1'-Cyanocytidine-5'-isobutyryl is a potent SARS-CoV-2 inhibitor in culture and infected Syrian hamstersFranck Amblard, Mahesh Kasthuri, Julia C LeCher, et al.Pageof 4